Correlation Between MorphoSys and Replimune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MorphoSys and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MorphoSys and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MorphoSys AG ADR and Replimune Group, you can compare the effects of market volatilities on MorphoSys and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MorphoSys with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of MorphoSys and Replimune.

Diversification Opportunities for MorphoSys and Replimune

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between MorphoSys and Replimune is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding MorphoSys AG ADR and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and MorphoSys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MorphoSys AG ADR are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of MorphoSys i.e., MorphoSys and Replimune go up and down completely randomly.

Pair Corralation between MorphoSys and Replimune

Considering the 90-day investment horizon MorphoSys AG ADR is expected to under-perform the Replimune. In addition to that, MorphoSys is 3.91 times more volatile than Replimune Group. It trades about -0.18 of its total potential returns per unit of risk. Replimune Group is currently generating about 0.07 per unit of volatility. If you would invest  936.00  in Replimune Group on September 29, 2024 and sell it today you would earn a total of  290.00  from holding Replimune Group or generate 30.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy22.22%
ValuesDaily Returns

MorphoSys AG ADR  vs.  Replimune Group

 Performance 
       Timeline  
MorphoSys AG ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MorphoSys AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, MorphoSys is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Replimune Group 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.

MorphoSys and Replimune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MorphoSys and Replimune

The main advantage of trading using opposite MorphoSys and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MorphoSys position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.
The idea behind MorphoSys AG ADR and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges